Rose Hurren

5.8k total citations
74 papers, 2.5k citations indexed

About

Rose Hurren is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Rose Hurren has authored 74 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 28 papers in Hematology and 12 papers in Oncology. Recurrent topics in Rose Hurren's work include Acute Myeloid Leukemia Research (21 papers), Ubiquitin and proteasome pathways (17 papers) and Protein Degradation and Inhibitors (17 papers). Rose Hurren is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Ubiquitin and proteasome pathways (17 papers) and Protein Degradation and Inhibitors (17 papers). Rose Hurren collaborates with scholars based in Canada, United States and India. Rose Hurren's co-authors include Aaron D. Schimmer, Marcela Gronda, Mark D. Minden, Alessandro Datti, Neil MacLean, Tabitha E. Wood, Robert A. Batey, Xinliang Mao, Xiaoming Wang and Jeffrey L. Wrana and has published in prestigious journals such as Blood, Molecular Cell and The Journal of Immunology.

In The Last Decade

Rose Hurren

70 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose Hurren Canada 30 1.5k 543 481 404 386 74 2.5k
Marcela Gronda Canada 27 1.5k 0.9× 488 0.9× 464 1.0× 334 0.8× 214 0.6× 56 2.2k
Yiqing Yang China 23 1.6k 1.0× 530 1.0× 549 1.1× 187 0.5× 308 0.8× 60 2.8k
Benjamin Yat‐Ming Yung Taiwan 35 2.6k 1.7× 542 1.0× 397 0.8× 326 0.8× 200 0.5× 116 3.7k
Jana Jakubı́ková Slovakia 28 1.4k 0.9× 554 1.0× 174 0.4× 457 1.1× 224 0.6× 78 2.2k
Shuang‐En Chuang Taiwan 34 1.9k 1.2× 791 1.5× 725 1.5× 156 0.4× 615 1.6× 75 3.3k
Yanhui Yang China 27 1.0k 0.7× 297 0.5× 402 0.8× 149 0.4× 240 0.6× 143 2.2k
Laurence Dubrez France 28 2.2k 1.4× 645 1.2× 335 0.7× 139 0.3× 561 1.5× 51 2.9k
Katarzyna Piwocka Poland 29 1.4k 0.9× 370 0.7× 202 0.4× 163 0.4× 288 0.7× 80 2.4k
Svetlana Karakhanova Germany 25 943 0.6× 712 1.3× 313 0.7× 136 0.3× 983 2.5× 39 2.5k
Astrid A. Ruefli Australia 14 2.6k 1.7× 1.0k 1.9× 422 0.9× 162 0.4× 394 1.0× 16 3.5k

Countries citing papers authored by Rose Hurren

Since Specialization
Citations

This map shows the geographic impact of Rose Hurren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Hurren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Hurren more than expected).

Fields of papers citing papers by Rose Hurren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Hurren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Hurren. The network helps show where Rose Hurren may publish in the future.

Co-authorship network of co-authors of Rose Hurren

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Hurren. A scholar is included among the top collaborators of Rose Hurren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Hurren. Rose Hurren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Yue, Yulia Jitkova, Jonathan St‐Germain, et al.. (2024). Abstract 7053: Serine phosphorylation marks proteins for degradation by the mitochondrial matrix protease, ClpXP. Cancer Research. 84(6_Supplement). 7053–7053.
2.
Barghout, Samir H., Asma M. Aman, Kazem Nouri, et al.. (2021). A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity. JCI Insight. 6(5). 24 indexed citations
3.
Schimmer, Aaron D., et al.. (2020). Transduction of Primary AML Cells with Lentiviral Vector for In Vitro Study or In Vivo Engraftment. STAR Protocols. 1(3). 100163–100163. 1 indexed citations
4.
5.
Coyaud, Étienne, Estelle Laurent, Rose Hurren, et al.. (2016). Characterizing the mitochondrial DNA polymerase gamma interactome by BioID identifies Ruvbl2 localizes to the mitochondria. Mitochondrion. 32. 31–35. 13 indexed citations
6.
Angka, Leonard, Andrew Mitchell, Rose Hurren, et al.. (2015). Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death. Cancer Research. 75(12). 2478–2488. 134 indexed citations
7.
Dove, Peter, Aisha Shamas‐Din, Alex Nachman, et al.. (2015). FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing. Cell Death and Disease. 6(7). e1815–e1815. 2 indexed citations
8.
Xu, G. Wei, Julia I. Toth, Stacey-Lynn Paiva, et al.. (2014). Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells. PLoS ONE. 9(4). e93530–e93530. 33 indexed citations
9.
Jitkova, Yulia, Marcela Gronda, Rose Hurren, et al.. (2014). A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity. PLoS ONE. 9(5). e95281–e95281. 33 indexed citations
10.
Simpson, Craig D., Rose Hurren, Dahlia Kasimer, et al.. (2012). A genome wide shRNA screen identifies α/β hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistance. APOPTOSIS. 17(7). 666–678. 19 indexed citations
11.
Zavareh, Reza Beheshti, Mahadeo A. Sukhai, Rose Hurren, et al.. (2012). Suppression of Cancer Progression by MGAT1 shRNA Knockdown. PLoS ONE. 7(9). e43721–e43721. 34 indexed citations
12.
Fonseca, Sonali B., Mark P. Pereira, Rida Mourtada, et al.. (2011). Rerouting Chlorambucil to Mitochondria Combats Drug Deactivation and Resistance in Cancer Cells. Chemistry & Biology. 18(4). 445–453. 93 indexed citations
13.
Wood, Tabitha E., Shadi Dalili, Craig D. Simpson, et al.. (2010). Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands. Molecular Cancer Therapeutics. 9(1). 246–256. 56 indexed citations
14.
Simpson, Craig D., Imtiaz A. Mawji, Kika Anyiwe, et al.. (2009). Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor Formation. Cancer Research. 69(7). 2739–2747. 84 indexed citations
15.
Schimmer, Aaron D., Michael P. Thomas, Rose Hurren, et al.. (2006). Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors. Cancer Research. 66(4). 2367–2375. 59 indexed citations
16.
Rabinovich, Brian, Jennifer Li, Martin F. Wolfson, et al.. (2006). NKG2D splice variants: a reexamination of adaptor molecule associations. Immunogenetics. 58(2-3). 81–88. 29 indexed citations
17.
Li, Jennifer, Brian Rabinovich, Rose Hurren, David Cosman, & Richard G. Miller. (2005). Survival versus neglect: redefining thymocyte subsets based on expression of NKG2D ligand(s) and MHC class I. European Journal of Immunology. 35(2). 439–448. 9 indexed citations
18.
Rabinovich, Brian, Jennifer Li, Rose Hurren, & Richard G. Miller. (2005). Immunosynapse formation coincides with rapid activation of NK cells by syngeneic T cells and correlates with clustering of MHC class I. International Immunology. 17(6). 671–676. 1 indexed citations
19.
Rabinovich, Brian, Jennifer Li, John P. Shannon, et al.. (2003). Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells. The Journal of Immunology. 170(7). 3572–3576. 178 indexed citations
20.
Li, M, Rose Hurren, Roman L. Zastawny, Victor Ling, & Roger Buick. (1999). Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium. British Journal of Cancer. 80(8). 1123–1131. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcela Gronda Breakdown of academic impact, for papers by Yiqing Yang Breakdown of academic impact, for papers by Benjamin Yat‐Ming Yung Breakdown of academic impact, for papers by Jana Jakubı́ková Breakdown of academic impact, for papers by Shuang‐En Chuang Breakdown of academic impact, for papers by Yanhui Yang Breakdown of academic impact, for papers by Laurence Dubrez Breakdown of academic impact, for papers by Katarzyna Piwocka Breakdown of academic impact, for papers by Svetlana Karakhanova Breakdown of academic impact, for papers by Astrid A. Ruefli
Rankless by CCL
2026